Found: 6
ОБЗОР2025 · pp. 19–29
Borodulina E.A., Yakovleva E.V., Borodulin B.E., Gladunova E.P., Marchenko S.D., Krylova O.V., Mamontova E.R., Rekalo A.R., Minnullina Z.R., Bagirova B.R., Salpagarova A.A.
Introduction. Allergic bronchial asthma (BA) is accompanied by activation of histamine H1/H4 receptors and variable response to antihistamines. The aim of this review is to analyze the molecular mechanisms of action of second- and third-generation antihistamin…
ОБЗОР2022
Sergeeva E.Y., Fefelova Y.A., Bardezkaya Y.V.
Personalized therapy allows to reveal subtypes of diseases with similar symptoms but various molecular mechanisms of development. Different -omics (genomics, epigenomics, transcriptomics, proteomics ets) are used to divide the diseases into subtypes. Transcrip…
ОБЗОР2019
Shirshova A.N., Boyarskikh U.A., Filipenko M.L., Pokrovsky V.S., Kushlinskii N.E.
The review highlights current data on molecular pathogenesis and potential markers of clear cell renal cell carcinoma, obtained in MultiOmyx studies. Key molecular mechanisms of the pathogenesis of RCC are the loss of functions of the VHL, PBRM1, SETD2, BAP1, …
ОБЗОР2018
Tsyganov M.M., Deryusheva I.V., Rodionov E.O., Ibragimova M.K., Miller S.V., Litviakov N.V.
Surgery results of the treatment of the stage II–III lung cancer remains to be unsatisfactory, and used the chemotherapy fails to improve the survival. The main obstacle is the use of standard clinical parameters for the treatment strategy and not enough effec…
Research article2014
Zenit-Zhuravleva E.G., Lushnikova A.A., Ponkratova D.A., Tsyganova I.V., Mikhailova I.N., Cheremushkin E.A., Vikhrova A.S., Treschalina E.M., Demidov L.V., Mazurenko N.N.
Introduction. The prevalence of human cutaneous melanoma (CM) in the world is constantly rising. Diagnostics and treatment of CM at the early stages allows to increase the 5-year patient survival up to 90%. This problem can be solved with personalized therapy …
ОБЗОР
Sergeeva E.Y., Fefelova Y.A., Bardezkaya Y.V.
Personalized therapy allows to reveal subtypes of diseases with similar symptoms but various molecular mechanisms of development. Different -omics (genomics, epigenomics, transcriptomics, proteomics ets) are used to divide the diseases into subtypes. Transcrip…